Ubigene Biosciences

Ubigene Biosciences is a specialized gene-editing provider offering efficient CRISPR-engineered cell lines and animal models for biomedical research. With a vast catalog of knockout, knock-in, and point-mutation cell lines, alongside high-throughput custom engineering capabilities, Ubigene streamlines functional genomics studies and drug target validation for global researchers.
Purchase from Ubigene Biosciences on Scientist.com

Three named platforms structure the Ubigene catalog: EZ-editor for knockout, EZ-HRex knockin, point-mutation, and iPSC editing; CRISPR-iScreen for library plasmids, viruses, cell pools, and in vitro or in vivo screens read out by NGS; and EZ-OE, a virus-free route to stable overexpression, knockdown, and luciferase reporter lines. Finished cell products sit in the Red Cotton OmniCell Bank, which lists more than 13,000 in-stock items across knockout, wild-type, Cas9 stable, OVA, EGFP, luciferase, and stem cell categories. Web tools accompany the services, including the Red Cotton CRISPR Gene Editing Designer, which returns three editing strategies per gene, assessment systems for gene dependency, expression level and copy number, and the iScreenAnlys platform for library analysis. Mouse genotyping and monoclone genotype validation kits round out the product line.